Literature DB >> 26100225

A superfusion apparatus for ex vivo human eye irritation investigations.

Hossein Mostafa Elbadawy1, Gianni Salvalaio2, Mohit Parekh2, Alessandro Ruzza2, Mattia Baruzzo2, Carlo Cagini3, Diego Ponzin2, Stefano Ferrari2.   

Abstract

A superfusion apparatus (SA) was developed to maintain isolated human corneas ex vivo under conditions which mimic the natural eye environment in vivo, including controlled temperature, tear flow and intraocular pressure. The SA was designed, developed and tested for use in ophthalmic pre-clinical research and to test new pharmaceutical formulations. Corneas undergo an equilibration process in the new physiological environment for one day. The test was then initiated by the application of the test substance, incubation, and temporal assessment of corneal damage using various parameters. The effects of mild and severe irritant concentrations of NaOH (2% and 8%, respectively) on corneal opacity, swelling and epithelial integrity were studied, and the inflammatory status assessed using F4/80 and MPO as macrophages and neutrophils markers, respectively. The SA was then used to test new artificial tear formulations supplemented with silver ions as an active constituent, showing different degrees of inflammatory responses as indicated by the migration of MPO and F4/80 positive cells towards the epithelium. The human cornea superfusion apparatus was proposed as a model for acute eye irritation research.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AgNO(3); Alternative method; Cornea; Ex vivo; NaOH

Mesh:

Substances:

Year:  2015        PMID: 26100225     DOI: 10.1016/j.tiv.2015.06.022

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  3 in total

1.  Development of a novel ex vivo equine corneal model.

Authors:  Todd L Marlo; Elizabeth A Giuliano; Ajay Sharma; Rajiv R Mohan
Journal:  Vet Ophthalmol       Date:  2016-07-29       Impact factor: 1.644

2.  Effect of connexin 43 inhibition by the mimetic peptide Gap27 on corneal wound healing, inflammation and neovascularization.

Authors:  Hossein Mostafa Elbadawy; Pierfrancesco Mirabelli; Maria Xeroudaki; Mohit Parekh; Marina Bertolin; Claudia Breda; Carlo Cagini; Diego Ponzin; Neil Lagali; Stefano Ferrari
Journal:  Br J Pharmacol       Date:  2016-08-26       Impact factor: 8.739

3.  Incremental Concentrations of Tacrolimus Eye Drops as a Strategy for the Management of Severe Vernal Keratoconjunctivitis.

Authors:  Maan Abdullah Albarry; Mohit Parekh; Stefano Ferrari; Heba Mahmoud Eltahir; Ahmed M Shehata; Mohamed A Shaker; Hossein Mostafa Elbadawy
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.